title: Alternative activation of macrophages and induction of arginase are not components of pathogenesis mediated by Francisella species.
abstract: Virulent Francisella tularensis ssp tularensis is an intracellular, Gram negative bacterium that causes acute lethal disease following inhalation of fewer than 15 organisms. Pathogenicity of Francisella infections is tied to its unique ability to evade and suppress inflammatory responses in host cells. It has been proposed that induction of alternative activation of infected macrophages is a mechanism by which attenuated Francisella species modulate host responses. In this report we reveal that neither attenuated F. tularensis Live Vaccine Strain (LVS) nor virulent F. tularensis strain SchuS4 induce alternative activation of macrophages in vitro or in vivo. LVS, but not SchuS4, provoked production of arginase1 independent of alternative activation in vitro and in vivo. However, absence of arginase1 did not significantly impact intracellular replication of LVS or SchuS4. Together our data establish that neither induction of alternative activation nor expression of arginase1 are critical features of disease mediated by attenuated or virulent Francisella species.
authors: Immunity to Pulmonary Pathogens Section, Laboratory of Intracellular Parasites, Rocky Mountain Veterinary Branch, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, Montana, United States of America.
authors: Amanda J
authors: AJ
authors: Griffin
authors: Deborah D
authors: DD
authors: Crane
authors: Tara D
authors: TD
authors: Wehrly
authors: Dana P
authors: DP
authors: Scott
authors: Catharine M
authors: CM
authors: Bosio
mesh_terms: D000818:Animals; D001119:Arginase / Q000096:biosynthesis*; D016207:Cytokines / Q000378:metabolism; D004790:Enzyme Induction; D005604:Francisella tularensis / Q000254:growth & development / Q000472:pathogenicity / Q000502:physiology*; D008168:Lung / Q000276:immunology / Q000382:microbiology / Q000473:pathology; D008262:Macrophage Activation; D008264:Macrophages / Q000201:enzymology* / Q000276:immunology / Q000382:microbiology* / Q000473:pathology; D051379:Mice; D008810:Mice, Inbred C57BL; D014406:Tularemia / Q000276:immunology / Q000382:microbiology / Q000517:prevention & control; D014613:Vaccines, Attenuated / Q000276:immunology
chemical_list: D016207:Cytokines; D014613:Vaccines, Attenuated; D001119:Arginase